ONVO News and Press, Organovo Holdings Inc. From 08/17/20

Aimed at regaining Nasdaq compliance of minimum bid price requirement for continued listing, Organovo Holdings (NASDAQ: ONVO ) will execute a 1-for-20 reverse split of its common stock at 5:00 pm ET on August 18. More news on: Organovo Holdings, Inc., Healthcare stocks news, ...

SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (the “Company”) (Nasdaq: ONVO) today announced that it filed a certificate of second amendment to its certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 rev...

Penny Stocks To Watch Before The End Of The Month There are now 5 trading sessions left before the end of May 2020. Penny stocks have been on fire once again. This trend continues a near 2-quarter long emphasis on micro-cap stocks under $5. As happy as we all are, let’s not get too ov...

Previously, I wrote how indiscriminate buying would be replaced with selectivity and that the market was approaching an important make-or-break moment following its rapid run-up since March. The S&P 500 remains below critical resistance, so the risk of weakness remains. However, our ...

Organovo Calls Off Merger Agreement with Tarveda, Market Responds Positively Organovo Holdings, Inc. ( ONVO ) reported that it has terminated its merger agreement with Tarveda Therapeutics Inc. The decision was taken in a reconvened special meeting where the company stockholders voted agai...

Organovo Holdings (NASDAQ: ONVO ) has terminated its planned merger with Tarveda Therapeutics after shareholders failed to back the tie-up. More news on: Organovo Holdings, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move, Read more ...

Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) announced today that it has terminated the merger agreement with Tarveda Therapeutics, Inc. (“Tarveda”), originally announced on December 16, 2019, and will continue to operate as an independent company. The Com...

Believes Stockholders Sent a Loud and Clear Message at Special Meeting That They Oppose This Value-Destructive Combination    Encourages Board of Directors to Heed Investor Feedback and Re-Focus on Bioprinting Urges Incumbent Directors to Resign if They Are Unwil...

Organovo Holdings, Inc. (“Organovo”) (Nasdaq: ONVO) convened, on March 26, 2020, the special meeting of stockholders (the “Special Meeting”) and then adjourned the Special Meeting until Tuesday, April 7, 2020 10:00 A.M. Pacific Time at www.virtualshareholdermeet...

Viscient will turn its attention to 3D bioprinting lung tissue for infectivity research to assist global efforts to combat SARS-CoV-2, the novel coronavirus that causes COVID-19 Organovo failed to receive a majority of stockholder votes in favor of its merger, and 47 million shares...